New MedInsight ebook: Gain a competitive edge with next-level employer group reporting
Advanced Employer Group Insights demonstrate the value of your health plan As healthcare costs rise, health plans need tools that enable them to demonstrate the value of their plans and provide data-backed answers to the questions that keep business owners up at night. How MedInsight Employer Group Insights (EGI) can help Backed by decades of … New MedInsight ebook: Gain a competitive edge with next-level employer group reporting
Step up your data-driven healthcare capabilities with the MedInsight Strategic Alliance Program
Improving the quality of patient care, after all, is the end game of everything we do at Milliman MedInsight. And while we bring decades of insight and experience to the effort, revolutionizing the future of healthcare is bigger than any single enterprise. It will require an ecosystem of strategic and technology alliances. That is a … Step up your data-driven healthcare capabilities with the MedInsight Strategic Alliance Program
Practice patterns of antibiotics prescriptions for URI
Antibiotics are prescribed at more than 100 million adult ambulatory care visits annually, and 41% of these prescriptions are for respiratory conditions. In the United States, at least 2 million antibiotic-resistant illnesses and 23,000 deaths occur each year, at a cost to the U.S. economy of at least $30 billion.1 The most common reason for … Practice patterns of antibiotics prescriptions for URI
Mitigating the impact of high-cost claimants with Employer Group Insights
It is widely recognized that a relatively small segment of a population can drive a significant percentage of overall healthcare expenditures. While some health plan members with minimal healthcare needs may not utilize any healthcare services, there are others who are high utilizers of the health system. Referred to as high-cost claimants, these individuals can … Mitigating the impact of high-cost claimants with Employer Group Insights
Addressing pharmacy drug trends with employer group reporting
According to a new study by the Business Group on Health, over 90% of employers reported concern over high-cost drugs and increasing pharmacy costs. This figure is not surprising when you consider that the average list price increase was nearly $150 per drug in January 2022 and rose to $250 by July 2022. During the … Addressing pharmacy drug trends with employer group reporting
Navigating payers’ top challenges: 3 strategies for success
The healthcare industry is on the precipice of a transformative era. As payers increasingly face a multitude of complex challenges, they are finding themselves at a critical juncture. One where they must navigate these issues alongside innovative, and sometimes, uncharted territory (e.g., emerging technology). At the Becker’s Spring Payer Issues Roundtable, Milliman MedInsight (MedInsight) collaborated … Navigating payers’ top challenges: 3 strategies for success